Management of Oral Discoid Lupus Erythematosus

Authors

  • Raziv Ganesha Department of Oral Medicine, Faculty of Dentistry, Universitas Mahasaraswati Denpasar, Bali, Indonesia

DOI:

https://doi.org/10.46862/interdental.v20i2.8974

Keywords:

ANA Test, Methylprednisolone, Oral Discoid Lupus Erythematosus

Abstract

Background: Systemic diseases have manifestations in the oral cavity with a variety of lesions that have similar types or forms and can be the first manifestations that appear before the manifestations spread to other areas, therefore a thorough initial examination of the oral cavity is very important to determine indications of systemic conditions. Lupus Erythematosus is an autoimmune disease that is associated with hyperactivity of the immune system, in which the immune system which functions as a protector of the body experiences an abnormality that is unable to distinguish between foreign objects /own cells. Oral Discoid Lupus Erythematosus is a manifestation of Systemic Lupus Erythematosus in the oral cavity.

Case: a 47-year-old woman came with complaints of canker sores in her mouth. Canker sores have occurred since the previous 7 months, sometimes heal and then reappear repeatedly. The patient said that she started experiencing thrush after giving birth 10 years ago.

Case Management: the patient was referred for a complete blood count and ANA test then the patient was given methylprednisolone 4 mg at a dose of 3x1 a day, topical anti-inflammatory drugs, and B-complex vitamins.

Discussion: Oral Discoid Lupus Erythematosus has clinical features of ulcers and erosions surrounded by white striae on the mucosal. Diagnosis confirmed from clinical features and ANA test which showed positive.

Conclusions: The treatment was successful because the correct diagnosis with collaboration was made to produce the right treatment plan accompanied by the patient's cooperation in carrying out the treatment

Downloads

Download data is not yet available.

References

Wahyuni IS, Dewi TS, Herawati E, Zakiawati D. Profil lesi oral pada penderita penyakit autoimun. Majalah kedokteran gigi Indonesia 2016; 2(3):147 -153.Doi: https://doi.org/10.22146/majkedgiind.11311

Ranginwala AM, Chalishazar MM, Panja P, Buddhdev KP, Kale HM. Oral discoid lupus erythematosus: A study of twenty-one cases Journal of Oral and Maxillofacial Pathology 2012;16(3):368-373. Doi: 10.4103/0973-029X.102487

Perhimpunan Reumatologi Indonesia. Diagnosis dan pengelolaan lupus eritematosus sistemik. 2011. www.reumatologi.or.id. [diakses tanggal 15 Juni 2016].

Bertias G, Cervera R, Boumpas DT. Eular Textbook on Rheumatic Disease. Ohio: BMJ; 2018. p. 476-505

Souirti Z, Lahlou M, Ouali OE, Chtaou N, Aarab C, Ghazouani FE, Bono W, Rammouz I, Belahsen F, Messouak O. Neuropsychiatric systemic lupus erythematosus. Open Journal of Rheumatology and Autoimmune Diseases 2013; 3(2):86-91. Doi: 10.4236/ojra.2013.32013

Cozzani E, Drosera M, Gasparini G, Parodi A. Serology of lupus erythematosus: correlation between immunopathological features and clinical aspects. Autoimmune Diseases 2014; 2014:321359. Doi: 10.1155/2014/321359

Maidhof W dan Hilas O. Lupus: an overview of the disease and management options. P&T: A Peer-Reviewed Journal for Formulary Management 2012; 37(4):240-246, 249.

Ray S, Sonthalia N, Kundu S, Ganguly S. Autoimmune Disorders: An Overview of Molecular and Cellular Basis in Today’s Perspective. J Clin Cell Immunol 2012; 6(1): 302. Doi: 10.4172/2155-9899.1000302

Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines For Clinical use of The Annuclear Antibody test and test for Specific antibodies to nuclear antigent. Arch Pathol Lab Med 2000;124(1):71-81. Doi: 10.5858/2000-124-0071-GFCUOT

Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, White T, Herold M, Bossuyt H, Musset L, Cervera, R, Plaza-Lopez A, Diaz C, Sousa MJ, Radice A, Eriksson C, Hultgren O, Viander M, Khamasta M, Regenass S, Andrade LC, Wiik A, Tincani A, Ronnelid J, Bloch B, Fritzler MJ, Chan EDK, Konstantinov K, Lahita R, Wilson M, Vainio O, Fabbien N, Sinico RA, Merconi P, Shoenfeld Y. International recommendation for the assessment of autoantibodies to cellular antigen referred to as antinuclear antibodies. Ann Reum Dis 2014;73(1):17-23

Wichalnus R. Sensitivity and specificity of ANA anti-nuclear antibody (ANA) Indirect Immunofluorescent Assay (IIFA) at varying titers for diagnosis LES: an evidence based approach for assessing the utility of ANA test in the clinical setting. Austin J Path Lab Med 2015:2(1);10-14

Dewoto HR. Farmakologi dan Terapi. Ed 5. Jakarta: FKUI; 2012. p. 283,505

Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D’Crus D, Empson B, Griffith B, Jayne D, Khamasta M, Lightstone L, Norton P, Norton Y, Scheiber K, Isenberg D. The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adult. Rheumatology 2018;57:1-45

Amissah-Arthur MB, Gordon C. Contemporary Treatment of Systemic Lupus Erythematosus: an update for clinician. The Adv Chronic Dis 2010; 1(4):163 -175.

Chang AY, Werth VP. Treatment of Cutaneous Lupus. Curr Rheumatol Rep 2011;13(4):300 -307.

Lokanata MD. Pemakaian Glukokortikoid pada Pengobatan. Jakarta: EGC; 2006. p.8-13,15-40

Sitompul R. Kortikosteroid dalam Tata Laksana Uveitis: Mekanisme Kerja, Aplikasi Klinis, dan Efek Samping. J Indon Med Assoc 2011; 61(6): 265-9

Touma Z, Urowitz MB. Systemic Glucocorticoid In: Tsokos GC. Editor Systemic Lupus Erythematosus Basic Applied and Clinical Aspects. Oxford: Elseiver; 2016. p.521-31

Kirou KA, Boumpas DT. Systemic Glucocorticoid Therapy. In:Walle DJ, Hanh BH. Editor. Dubois lupus erythematosus and relates syndrome. 8th Edition. Philadelphia: Elseive Saunders; 2013. p. 591-600

Downloads

Published

2024-08-01

How to Cite

1.
Ganesha R. Management of Oral Discoid Lupus Erythematosus. interdental [Internet]. 2024 Aug. 1 [cited 2024 Nov. 21];20(2):293-9. Available from: https://e-journal.unmas.ac.id/index.php/interdental/article/view/8974

Most read articles by the same author(s)